2011 Clinical Trials Patients Strains 
Greencamp
FEBRUARY 17, 2019
The stress response in IBS patients causes abnormalities in the functioning of the sympathetic nervous system (one of the divisions of the autonomic or “subconscious” nervous system) and to the HPA axis. During a three-month period, 13 patients with long-standing IBS were given cannabis. How to choose the best strain for IBS?
The Cannigma
JUNE 23, 2022
The study also found that CBGA interacts with numerous other important receptors in the body like GPR55, TRPV1 channels, as well as GABA receptors, supporting further consideration and research for use in epileptic patients. A 2011 in vitro study examined the anti-inflammatory properties of six different cannabinoids, including CBGA.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Cannigma
FEBRUARY 11, 2021
Listen & Subscribe: When Mara Gordon started using medical cannabis there wasn’t any lab testing — or any way to know how much of each cannabinoid or terpene was in a given strain. One of the things she does is collect and analyze data about cannabis products and how patients with different medical conditions respond to them.
SMPL
MAY 26, 2020
After two years of tracking down high-CBD pot plants and building momentum, the group began to devise ways to persuade more farmers to grow strains with CBD — which had largely been bred out of American pot since it doesn’t get you high. Both pledged to keep their strains available for other growers at cheap prices. (Mr.
Cannabis Law Report
FEBRUARY 25, 2019
Syqe Medical was founded in 2011 in order to develop a measurable and repeatable method of administering medical cannabis. We like the fact that in some of its strains, the product has a psychoactive effect. They discovered that the product has to be simple to use because some of the patients are already past their cognitive peaks.
Cannabis Law Report
OCTOBER 29, 2019
Wakshlag is well-known in the veterinary medicine community as the first doctor to conduct an efficacy study in dogs in a clinical trial at Cornell using ElleVet CBD/CBDA on dogs with multi-joint discomfort. The clinical trial results confirmed more than 80% of dogs showed significant or dramatic improvement.
Green Relief
MAY 13, 2018
A 2014 study found that traumatic brain injury ( TBI ) patients who tested positive for THC were more likely to survive with less impairment than TBI patients who abstained from marijuana. As yet there have been no FDA -approved clinical trials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury.
Expert insights. Personalized for you.
96 
Let's personalize your content